KIRK WILHELMUS to Disease Models, Animal
This is a "connection" page, showing publications KIRK WILHELMUS has written about Disease Models, Animal.
Connection Strength
0.422
-
Expression of small leucine-rich proteoglycans during experimental fungal keratitis. Cornea. 2010 Jun; 29(6):674-9.
Score: 0.150
-
Immunosuppression affects the severity of experimental Fusarium solani keratitis. J Infect Dis. 2004 Jul 01; 190(1):192-8.
Score: 0.099
-
Program planning for research on Acanthamoeba. Rev Infect Dis. 1991 Mar-Apr; 13 Suppl 5:S446-50.
Score: 0.040
-
Expression of matrix metalloproteinases during experimental Candida albicans keratitis. Invest Ophthalmol Vis Sci. 2009 Feb; 50(2):737-42.
Score: 0.034
-
Expression of matrix metalloproteinases 2 and 9 in experimental corneal injury and fungal keratitis. Cornea. 2007 Jun; 26(5):589-93.
Score: 0.030
-
Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis. Invest Ophthalmol Vis Sci. 2007 Feb; 48(2):774-80.
Score: 0.030
-
Topical FK-506 prevents experimental corneal allograft rejection. Cornea. 1995 Mar; 14(2):157-60.
Score: 0.013
-
Pathogenesis and outcome of Paecilomyces keratitis. Am J Ophthalmol. 2009 Apr; 147(4):691-696.e3.
Score: 0.009
-
The role of secreted aspartyl proteinases in Candida albicans keratitis. Invest Ophthalmol Vis Sci. 2007 Aug; 48(8):3559-65.
Score: 0.008
-
Experimental keratomycosis in a mouse model. Invest Ophthalmol Vis Sci. 2003 Jan; 44(1):210-6.
Score: 0.006
-
Comparative bioavailability and efficacy of fortified topical tobramycin. Invest Ophthalmol Vis Sci. 1987 May; 28(5):881-5.
Score: 0.002
-
Intracanalicular collagen implants enhance topical antibiotic bioavailability. Cornea. 1986; 5(3):167-71.
Score: 0.002